Citation: J. Ford et al., A PHASE-I STUDY OF INTRAVENOUS RMP-7 WITH CARBOPLATIN IN PATIENTS WITH PROGRESSION OF MALIGNANT GLIOMA, European journal of cancer, 34(11), 1998, pp. 1807-1811
Authors:
MIDDLETON MR
LUNN JM
MORRIS C
RUSTIN G
WEDGE SR
BRAMPTON MH
LIND MJ
LEE SM
NEWELL DR
BLEEHEN NM
NEWLANDS ES
CALVERT AH
MARGISON GP
THATCHER N
Citation: Mr. Middleton et al., O-6-METHYLGUANINE-DNA METHYLTRANSFERASE IN PRETREATMENT TUMOR-BIOPSIES AS A PREDICTOR OF RESPONSE TO TEMOZOLOMIDE IN MELANOMA, British Journal of Cancer, 78(9), 1998, pp. 1199-1202
Authors:
HAWKINS RE
RUSSELL SJ
MARCUS R
ASHWORTH LJ
BRISSNIK J
ZHANG J
WINTER G
BLEEHEN NM
STEVENSON F
HAMBLIN T
OSCIER D
ZHU DL
KING C
KUMAR S
THOMPSETT A
STEVENSON GT
Citation: Re. Hawkins et al., A PILOT-STUDY OF IDIOTYPIC VACCINATION FOR FOLLICULAR B-CELL LYMPHOMAUSING A GENETIC APPROACH, Human gene therapy, 8(10), 1997, pp. 1287-1299
Citation: R. Jayasundar et al., THE EFFECTS OF ANESTHESIA AND PHYSICAL RESTRAINT ON INTRACELLULAR ANDEXTRACELLULAR TUMOR PH, TUMOR TEMPERATURE AND BIOENERGETICS IN MURINERIF-1 TUMORS, Magnetic resonance imaging, 15(7), 1997, pp. 847-855
Authors:
BOWER M
NEWLANDS ES
BLEEHEN NM
BRADA M
BEGENT RJH
CALVERT H
COLQUHOUN I
LEWIS P
BRAMPTON MH
Citation: M. Bower et al., MULTICENTER CRC PHASE-II TRIAL OF TEMOZOLOMIDE IN RECURRENT OR PROGRESSIVE HIGH-GRADE GLIOMA, Cancer chemotherapy and pharmacology, 40(6), 1997, pp. 484-488
Authors:
BOOTE DJ
DENNIS IF
TWENTYMAN PR
OSBORNE RJ
LABURTE C
HENSEL S
SMYTH JF
BRAMPTON MH
BLEEHEN NM
Citation: Dj. Boote et al., PHASE-I STUDY OF ETOPOSIDE WITH SDZ PSC 833 AS A MODULATOR OF MULTIDRUG-RESISTANCE IN PATIENTS WITH CANCER, Journal of clinical oncology, 14(2), 1996, pp. 610-618
Authors:
GIRLING DJ
THATCHER N
CLARK PI
HOPWOOD P
TWIDDY S
STEPHENS RJ
BAILEY AJ
MACHIN D
BLEEHEN NM
BOLGER JJ
CONNOLLY CK
HASLETON PS
MACBETH FR
MOGHISSI K
SAUNDERS MI
WHITE RJ
ALCOCK S
BURT H
CROSSLEY E
DECKER E
ENGLISH J
FOSTER G
HANNIGAN K
HERON D
HUTCHINSON J
LOMAX L
MERCER V
PAGE S
ROTHWELL T
STAINES K
TAYLORNEAL P
TURNBALL V
AXFORD AT
EARL HM
GLAHOLM J
FALK SJ
GRAHAM JD
JONES DK
COOMBES RC
EPSTEIN RJ
HANHAM I
LOWDELL CP
NEWLANDS E
SMITH DB
COOKSON JB
ANDERSON H
GRIBBIN HR
SINCLAIR DJM
CARMICHAEL J
CHAN SYT
JOHNSTON IDA
MORGAN SA
DUNN KS
MANIFOLD IH
RADSTONE DJ
LAMONT A
ROBINSON ACR
BISSETT D
NICOLSON MC
TANG OT
SINNAMON DG
VARGHESE G
BIBBY RJ
OREILLY JF
BATH JCJ
BREDIN CP
STEWART SJ
WHILLIS D
WILTSHIRE CR
MCILLMURRAY MB
BOND MG
WARDMAN AG
BOZZINO JM
FERGUSON GC
MACMILLAN CH
SUGDEN EM
TALBOT DC
QUIGLEY IG
WEATHERSTONE RM
VEALE D
OREGAN PF
Citation: Dj. Girling et al., COMPARISON OF ORAL ETOPOSIDE AND STANDARD INTRAVENOUS MULTIDRUG CHEMOTHERAPY FOR SMALL-CELL LUNG-CANCER - A STOPPED MULTICENTER RANDOMIZED TRIAL, Lancet, 348(9027), 1996, pp. 563-566
Authors:
BLEEHEN NM
GIRLING DJ
HOPWOOD P
LALLEMAND G
MACHIN D
STEPHENS RJ
BAILEY AJ
Citation: Nm. Bleehen et al., RANDOMIZED TRIAL OF 4-DRUG VS LESS INTENSIVE 2-DRUG CHEMOTHERAPY IN THE PALLIATIVE TREATMENT OF PATIENTS WITH SMALL-CELL LUNG-CANCER (SCLC)AND POOR-PROGNOSIS (VOL 73, PG 406, 1996), British Journal of Cancer, 74(6), 1996, pp. 997-997
Authors:
STEPHENS RJ
GIRLING DJ
BLEEHEN NM
MOGHISSI K
YOSEF HMA
MACHIN D
Citation: Rj. Stephens et al., THE ROLE OF POSTOPERATIVE RADIOTHERAPY IN NON-SMALL-CELL LUNG-CANCER - A MULTICENTER RANDOMIZED TRIAL IN PATIENTS WITH PATHOLOGICALLY STAGED T1-2N1-2,M(0) DISEASE, British Journal of Cancer, 74(4), 1996, pp. 632-639
Authors:
HONESS DJ
KITAMOTO Y
RAMPLING MR
BLEEHEN NM
Citation: Dj. Honess et al., NICOTINAMIDE AND PENTOXIFYLLINE INCREASE HUMAN-LEUKOCYTE FILTERABILITY - A POSSIBLE MECHANISM FOR REDUCTION OF ACUTE-HYPOXIA, British Journal of Cancer, 74, 1996, pp. 236-240
Authors:
BLEEHEN NM
GIRLING DJ
HOPWOOD P
LALLEMAND G
MACHIN D
STEPHENS RJ
BAILEY AJ
Citation: Nm. Bleehen et al., RANDOMIZED TRIAL OF 4-DRUG VS LESS INTENSIVE 2-DRUG CHEMOTHERAPY IN THE PALLIATIVE TREATMENT OF PATIENTS WITH SMALL-CELL LUNG-CANCER (SCLC)AND POOR-PROGNOSIS, British Journal of Cancer, 73(3), 1996, pp. 406-413
Citation: Jg. Reeve et al., INSULIN-LIKE GROWTH-FACTOR (IGF) AND IGF BINDING-PROTEINS IN GROWTH-HORMONE DYSREGULATION AND ABNORMAL GLUCOSE-TOLERANCE IN SMALL-CELL LUNG-CANCER PATIENTS, European journal of cancer, 31A(9), 1995, pp. 1455-1460
Authors:
BLEEHEN NM
NEWLANDS ES
LEE SM
THATCHER N
SELBY P
CALVERT AH
RUSTIN GJS
BRAMPTON M
STEVENS MFG
Citation: Nm. Bleehen et al., CANCER-RESEARCH CAMPAIGN PHASE-II TRIAL OF TEMOZOLOMIDE IN METASTATICMELANOMA, Journal of clinical oncology, 13(4), 1995, pp. 910-913
Citation: Dj. Honess et al., PENTOXIFYLLINE INCREASES RIF-1 TUMOR PO(2) IN A MANNER COMPATIBLE WITH ITS ABILITY TO INCREASE RELATIVE TUMOR PERFUSION, Acta oncologica, 34(3), 1995, pp. 385-389
Citation: Dg. Frew et al., RESPONSE OF 145 SPONTANEOUS CANINE HEAD AND NECK TUMORS TO RADIATION VERSUS RADIATION PLUS MICROWAVE HYPERTHERMIA - RESULTS OF A RANDOMIZEDPHASE-III CLINICAL-STUDY, International journal of hyperthermia, 11(2), 1995, pp. 217-230
Authors:
REEVE JG
GUADANO A
XIONG JY
MORGAN J
BLEEHEN NM
Citation: Jg. Reeve et al., DIMINISHED EXPRESSION OF INSULIN-LIKE GROWTH-FACTOR (IGF) BINDING PROTEIN-5 AND ACTIVATION OF IGF-I-MEDIATED AUTOCRINE GROWTH IN SIMIAN-VIRUS 40-TRANSFORMED HUMAN FIBROBLASTS, The Journal of biological chemistry, 270(1), 1995, pp. 135-142
Authors:
KERR DJ
RUSTIN GJ
KAYE SB
SELBY P
BLEEHEN NM
HARPER P
BRAMPTON MH
Citation: Dj. Kerr et al., PHASE-II TRIALS OF RHIZOXIN IN ADVANCED OVARIAN, COLORECTAL AND RENAL-CANCER, British Journal of Cancer, 72(5), 1995, pp. 1267-1269
Authors:
BLEEHEN NM
NEWMAN HVF
RAMPLING RP
RAMSAY JR
ROBERTS JT
BEDFORD P
NETHERSELL ABW
Citation: Nm. Bleehen et al., A PHASE-II STUDY OF ORAL PIRITREXIM IN RECURRENT HIGH-GRADE (III, IV)GLIOMA, British Journal of Cancer, 72(3), 1995, pp. 766-768
Citation: Vm. Laurence et al., CARBOGEN BREATHING WITH NICOTINAMIDE IMPROVES THE OXYGEN STATUS OF TUMORS IN PATIENTS, British Journal of Cancer, 72(1), 1995, pp. 198-205
Citation: Dj. Honess et Nm. Bleehen, PERFUSION CHANGES IN THE RIF-1 TUMOR AND NORMAL-TISSUES AFTER CARBOGEN AND NICOTINAMIDE, INDIVIDUALLY AND COMBINED, British Journal of Cancer, 71(6), 1995, pp. 1175-1180
Authors:
JEBB SA
OSBORNE RJ
DIXON AK
BLEEHEN NM
ELIA M
Citation: Sa. Jebb et al., MEASUREMENTS OF RESTING ENERGY-EXPENDITURE AND BODY-COMPOSITION BEFORE AND AFTER TREATMENT OF SMALL-CELL LUNG-CANCER, Annals of oncology, 5(10), 1994, pp. 915-919
Authors:
STEPHENS RJ
GIRLING DJ
MACHIN D
THATCHER N
BLEEHEN NM
BOLGER JJ
CLARK PI
HASLETON PS
HOPWOOD P
MACBETH FR
MOGHISSI K
SAUNDERS MI
WHITE RJ
Citation: Rj. Stephens et al., TREATMENT-RELATED DEATHS IN SMALL-CELL LUNG-CANCER TRIALS - CAN PATIENTS AT RISK BE IDENTIFIED, Lung cancer, 11(3-4), 1994, pp. 259-274
Authors:
BLEEHEN NM
BALL D
BELANI CP
BISHOP J
DOUILLARD JY
COX JD
JOHNSON DH
LECHEVALIER T
SAUNDERS MI
SHAW E
SCHAAKEKONING C
TANNOCK I
TROVO M
TURRISI AT
VANHOUTTE P
Citation: Nm. Bleehen et al., COMBINED RADIATION AND CHEMOTHERAPY FOR UNRESECTABLE NONSMALL CELL LUNG-CARCINOMA, Lung cancer, 10, 1994, pp. 190000019-190000023
Authors:
FALK SJ
RAMSAY JR
WARD R
MILES K
DIXON AK
BLEEHEN NM
Citation: Sj. Falk et al., BW12C PERTURBS NORMAL AND TUMOR-TISSUE OXYGENATION AND BLOOD-FLOW IN MAN, Radiotherapy and oncology, 32(3), 1994, pp. 210-217
Authors:
SMITH PJ
SOUES S
GOTTLIEB T
FALK SJ
WATSON JV
OSBORNE RJ
BLEEHEN NM
Citation: Pj. Smith et al., ETOPOSIDE-INDUCED CELL-CYCLE DELAY AND ARREST-DEPENDENT MODULATION OFDNA TOPOISOMERASE-II IN SMALL-CELL LUNG-CANCER CELLS, British Journal of Cancer, 70(5), 1994, pp. 914-921